stockrow
Friday 6 November 2026
Export SKIN’s income statement to Excel — free account
SkinHealth Systems Inc.
SKIN Consumer Defensive Household & Personal Products
SkinHealth Systems Inc.’s revenue for fiscal 2025 (year ended December 2025) was $300.8 million, down 10.0% from fiscal 2024.
- Revenue
- −2.10%
- EPS
- −112.5%
- Free cash flow
- +19.1%
- Total debt
- −33.1%
Quarter to September 2026, against a year earlier
15.08
4.73
+45.70%
Follow SKIN
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
6 | 8 | 4 | 3 | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 28.91 | 0.00 | 0.00 | 0.00 | — |
P/S ratio |
0.58 | 0.59 | 1.02 | 3.72 | 9.49 | 0.00 | 0.00 | — |
Altman Z-Score |
(0.45) | 0.03 | 0.28 | 1.57 | 2.15 | 1.08 | — | — |
P/FCF ratio |
5.43 | 21.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Altman Z″-Score (non-manufacturers) |
(1.89) | 0.92 | 1.56 | 3.46 | 3.98 | (0.45) | — | — |
Beneish M-Score |
(3.05) | (3.35) | (2.94) | (1.31) | (3.05) | — | — | — |
P/Operating CF |
11.56 | 11.95 | (78.70) | (252.26) | 752.39 | (594.72) | (978.70) | — |
P/B ratio |
2.88 | 3.80 | 6.85 | 8.14 | 8.16 | 130.07 | 16,325.50 | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 20.12 | 0.00 | 16,325.50 | — |
EV/Sales |
1.02 | 1.15 | 1.58 | 4.19 | 8.84 | 0.00 | 0.00 | — |
EV/EBITDA |
37.57 | 0.00 | 0.00 | 1,216.01 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
8.20 | 23.80 | 28.84 | (14.38) | (81.07) | (75.84) | 0.00 | — |
EV/FCF |
9.51 | 41.12 | (64.29) | (12.22) | (52.28) | (75.84) | 0.00 | — |
Quick Ratio |
1.37 | 5.85 | 5.03 | 9.01 | 12.47 | 1.06 | — | — |
Current Ratio |
1.66 | 7.00 | 6.07 | 10.92 | 13.09 | 1.91 | — | — |
Net Debt/EBITDA |
16.10 | (5.92) | (2.34) | 137.15 | 9.36 | (176.97) | 0.00 | — |
Debt/Assets |
72.91% | 80.53% | 79.47% | 73.89% | 60.22% | 97.17% | 0.00% | 0.00% |
Debt/Equity |
5.97 | 10.66 | 12.43 | 4.44 | 2.43 | (7.23) | 0.00 | — |
Asset Turnover |
0.51 | 0.41 | 0.41 | 0.33 | 0.36 | 1.07 | 0.00 | — |
Operating CF/Net income |
(3.94) | (0.55) | (0.22) | (2.41) | 0.07 | 0.43 | (1.05) | — |
Capex/Depreciation |
(0.18) | (0.18) | (0.81) | (0.70) | (0.71) | (0.24) | (0.69) | — |
Interest Coverage |
(1.08) | (6.51) | (9.59) | (1.93) | (3.39) | (0.81) | 0.79 | — |
| (16.87%) | (52.34%) | (88.42%) | 18.84% | (278.16%) | (21.45%) | 0.00% | — | |
| (1.61%) | (3.60%) | (10.36%) | 3.98% | (52.55%) | (26.19%) | 0.00% | — | |
ROIC |
(6.74%) | (18.11%) | (29.78%) | (4.75%) | (18.58%) | (6.06%) | 0.00% | — |
Return on Tangible Assets |
(7.57%) | (7.01%) | (16.76%) | 6.06% | (40.27%) | (78.10%) | 0.00% | — |
Average Days of Receivables |
28.44 | 31.08 | 50.47 | 77.59 | 72.17 | 71.06 | 0.00 | — |
Research and Development Expense of Revenue |
1.87% | 1.88% | 2.54% | 2.31% | 3.15% | 2.86% | 2.77% | — |
Selling, General and Administrative Expense of Revenue |
70.33% | 72.92% | 69.33% | 72.75% | 80.85% | 67.99% | 53.08% | — |
Intangible Assets out of Total Assets |
0.32 | 0.25 | 0.20 | 0.17 | 0.15 | 0.67 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
4.93% | 7.99% | 5.66% | 7.79% | 4.77% | 0.30% | 0.06% | — |
Graham Net Nets |
(0.74) | (0.80) | (0.42) | (0.04) | 0.03 | (0.02) | 0.00 | — |
Graham Number |
0.00 | 0.00 | 0.00 | 57.01 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
(5.04%) | (14.71%) | (24.92%) | 3.46% | (13.92%) | (0.18%) | (0.18%) | — |
Free Cash Flow Yield |
18.40% | 4.74% | (2.40%) | (9.22%) | (1.78%) | (1.75%) | 0.00% | — |
Revenue per Share |
47.60 | 53.99 | 60.45 | 49.59 | 50.94 | 69.45 | 103.70 | — |
Operating CF per Share |
5.93 | 2.61 | 3.30 | (14.45) | (5.55) | (7.25) | 1.08 | — |
Capex per Share |
(0.82) | (1.10) | (4.79) | (2.56) | (3.06) | (2.23) | (6.49) | — |
Free Cash Flow per Share |
5.12 | 1.51 | (1.48) | (17.01) | (8.61) | (9.48) | (5.41) | — |
Cash per Share |
36.82 | 59.77 | 79.44 | 77.02 | 176.64 | 5.53 | 0.00 | — |
Shareholders Equity per Share |
9.66 | 8.37 | 9.02 | 22.64 | 59.21 | (17.47) | 0.00 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
9.66 | 8.37 | 9.02 | 22.64 | 59.21 | (17.47) | 0.00 | — |
Free Cash Flow |
32.32 | 9.34 | (9.76) | (125.47) | (43.98) | (16.25) | (8.69) | — |
Working Capital |
123.24 | 408.97 | 583.24 | 711.56 | 924.46 | 28.17 | — | — |
Capital Expenditures |
(5.16) | (6.79) | (31.51) | (18.87) | (15.62) | (3.82) | (10.42) | — |
Net Current Asset Value |
(129.23) | (156.76) | (171.47) | (52.75) | 84.38 | (193.70) | 0.00 | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.02 | 0.02 | 0.08 | 0.05 | 0.06 | 0.03 | 0.06 | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
11.42 | 6.19 | 2.73 | 1.49 | 1.36 | 1.74 | 0.00 | — |
Cash ROIC |
4.91% | 0.96% | (0.74%) | (8.50%) | (2.27%) | (8.29%) | 0.00% | — |
Accounts Receivable Turnover |
11.59 | 8.01 | 5.99 | 5.66 | 6.97 | 3.22 | 0.00 | — |
Accounts Payable Turnover |
5.56 | 4.56 | 6.63 | 4.07 | 3.43 | 2.21 | 0.00 | — |
Inventory Turnover |
1.78 | 1.89 | 2.42 | 1.62 | 2.79 | 1.79 | 0.00 | — |
Average Days of Payables |
54.64 | 52.69 | 67.28 | 88.73 | 130.02 | 130.02 | 0.00 | — |
Days of Inventory on Hand |
167.82 | 165.96 | 137.24 | 341.81 | 157.82 | 163.20 | 0.00 | — |
Average Receivables |
25.95 | 41.75 | 66.40 | 64.60 | 37.31 | 37.00 | — | — |
Average Payables |
18.79 | 33.35 | 36.62 | 28.76 | 23.77 | 23.50 | — | — |
Average Inventory |
58.56 | 80.22 | 100.49 | 72.46 | 29.23 | 29.00 | — | — |
Average Assets |
592.74 | 807.40 | 966.10 | 1,110.94 | 720.82 | 111.42 | 0.00 | — |
Average Common Equity |
56.43 | 55.60 | 113.22 | 234.68 | 136.17 | 136.00 | — | — |
Columns are period end dates · fundamentals updated 5 Nov 2026